Nanjing Sinolife United Co Ltd
03332
Company Profile
Business description
Nanjing Sinolife United Co Ltd is a company based in China, predominantly engaged in producing and selling nutritional supplements and the trading of packaged health food products. Its product offerings include Zhongsheng Coenzyme capsules, Guishi Weisi capsules, and Green Zhi capsules, among others. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from New Zealand, Australia, Vietnam, and other countries.
Contact
3 Qingma Road
4th Floor, Building 3
Qixia District
Jiangsu Province
Nanjing
CHNT: +86 2586819188
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2026
Employees
481
Stocks News & Analysis
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
stocks
Revenue growth on track for undervalued ASX healthcare stock
Near-term cost growth does not change our long-term view.
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,132.90 | 11.10 | 0.12% |
| CAC 40 | 8,245.80 | 18.07 | -0.22% |
| DAX 40 | 23,806.99 | 273.64 | -1.14% |
| Dow JONES (US) | 48,185.80 | 275.88 | 0.58% |
| FTSE 100 | 10,603.48 | 5.40 | -0.05% |
| HKSE | 25,900.14 | 147.74 | 0.57% |
| NASDAQ | 22,822.42 | 187.42 | 0.83% |
| Nikkei 225 | 56,728.95 | 833.63 | 1.49% |
| NZX 50 Index | 13,164.39 | 109.42 | -0.82% |
| S&P 500 | 6,824.66 | 41.85 | 0.62% |
| S&P/ASX 200 | 8,940.10 | 15.70 | 0.18% |
| SSE Composite Index | 3,998.74 | 32.56 | 0.82% |